Učitavanje...
Imaging biomarkers of NAFLD, NASH, and fibrosis
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a clinicopathologic entity that requires a liver biopsy assessment to diagnose the progressive form of NAFLD called non-alcoholic steatohepatitis (NASH). Liver biopsy is invasive, subject to sampling and interobserver variability, and impracti...
Spremljeno u:
| Izdano u: | Mol Metab |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8324681/ https://ncbi.nlm.nih.gov/pubmed/33460786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2021.101167 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|